Phase 1 Safety Study of ALK-001 in Healthy Volunteers

Clinical trial NCT02230228 · COMPLETED

Trial details

NCT number: NCT02230228
Sponsor: Alkeus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Stargardt Disease Age-related Macular Degeneration Other Retinal Dystrophies

Start date: 2014-04-01
Primary completion: 2014-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.